Adept adds two support staff

For expanding range of data acquisition products

Adept Scientific, based in Letchworth, Hertfordshire, UK, has taken on two new members of staff to support its expanding range of data acquisition products (DAQ).

Henrique da Silva will concentrate on DAQ sales. He has an MSc in Electronics & Computer Engineering.

Elizabeth Northrop (Lilly) will focus on technical support. She has an MEng in Systems Engineering.

With offices in the UK, Germany and throughout the Nordic region, Adept Scientific is a supplier of software and hardware products for research, scientific, engineering and technical applications on desktop computers.

You may also like

Sustainability

Free online course introduces fundamentals of SFC

Learn how SFC can improve efficiency and reduce environmental impact
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Top trends in industrial monitoring and control

Monitoring and control advancements are central to driving productivity, resilience and profitability in every enterprise, reports Andy Graham, Solutions Manager at SolutionsPT
Manufacturing

Thermo Fisher launches general purpose centrifuges with natural refrigerant cooling

New X and S Series models offer high performance with reduced environmental impact
Research & Development

€2.5m boost for SensABLATE to revolutionise real-time lung cancer treatment

The next-generation AI and photonics system is designed to provide instant intraoperative confirmation during lung cancer ablation and aims to improve precision, reduce repeat procedures and enhance patient outcomes
Regulatory

FDA grants Medivir’s MIV-711 Orphan Drug Designation for Osteogenesis Imperfecta treatment

The FDA has awarded Orphan Drug Designation to Medivir’s selective cathepsin K inhibitor MIV-711 for Osteogenesis Imperfecta, a rare genetic bone disorder, after preclinical and clinical data suggests the therapy may strengthen bone
Research & Development

Vivan Therapeutics and MRC LMS launch partnership to study how KRAS mutations, diabetes and diet shape cancer drug response

The new collaboration will investigate how KRAS mutations and metabolic conditions such as diabetes influence chemotherapy effectiveness, using high-throughput in vivo “fly avatar” models
Digital

Survey: 65% of pharma marketers distrust AI for regulatory submissions amid fears about hallucinations and traceability

A new survey reveals deep scepticism toward AI-generated regulatory materials, with pharma teams citing hallucinations, poor auditability and lack of transparency as major risks
Subscribe now